Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol
Thomas Lehnert, Christian Röver, Sascha Köpke, Jordi Rio, Declan Chard, Andrea V. Fittipaldo, Tim Friede, Christoph Heesen, Anne C. Rahn*
Dive into the research topics of 'Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol'. Together they form a unique fingerprint.